Clinical Trial Update: Diabeloop WP6.2 : Crossover Evaluation of Glycemic Control [Phase 2]

View source ↗

Summary

A Phase 2 crossover trial evaluating glycemic control with the Diabeloop WP6.2 closed-loop insulin delivery system in adults with type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Diabeloop WP6.2 Closed-Loop System

Snippet

Sponsor: Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète | Conditions: Closed Loop, Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED